Source: Nutraceutical Business Review

Rousselot: Rousselot's softgel technology, StabiCaps, granted Brazilian patent

The gelatin-based capsule technology optimises the release of nutraceuticals from a softgel, allowing functional ingredient manufacturers to produce efficacious and bioavailable dietary supplements

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more